EFIB 2022 Vilnius Statement wider launch

Industrial Biotechnology for a sustainable society: a focus for 2023 and beyond
 
Industrial biotechnology and biomanufacturing are recognised as being part of the response to some of today’s pressing global challenges. Delivering on EU Green Deal objectives whilst strengthening resilience and independence of European industries is increasingly critical. 

The inaugural EFIB Statement of October 2021 created a baseline for industrial biotechnology and bioeconomy vision in policy, regulatory and landscape development. The EuropaBio’s EFIB Vilnius Statement of 2022 evolves to address this long-term vision and ambition within the context of challenges and needs over the next 12 months. 

We invite you to join us for a discussion on the role and potential of enabling technologies in the EU green transition, with a focus on priorities for the shorter term and building up to the longer term.